Cargando…
Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC
Diffuse large B cell lymphoma (DLBCL) is a common and fatal hematological malignancy. Long noncoding RNAs (lncRNAs) have emerged as crucial biomarkers and regulators in many cancers. Novel lncRNA biomarker in DLBCL needs to be investigated badly, as well as its function and molecular mechanism. To f...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420660/ https://www.ncbi.nlm.nih.gov/pubmed/30874550 http://dx.doi.org/10.1038/s41419-019-1479-3 |
_version_ | 1783404120537825280 |
---|---|
author | Zhao, Chen-Chen Jiao, Yang Zhang, Yi-Yin Ning, Jie Zhang, Yi-Ruo Xu, Jing Wei, Wei Kang-Sheng, Gu |
author_facet | Zhao, Chen-Chen Jiao, Yang Zhang, Yi-Yin Ning, Jie Zhang, Yi-Ruo Xu, Jing Wei, Wei Kang-Sheng, Gu |
author_sort | Zhao, Chen-Chen |
collection | PubMed |
description | Diffuse large B cell lymphoma (DLBCL) is a common and fatal hematological malignancy. Long noncoding RNAs (lncRNAs) have emerged as crucial biomarkers and regulators in many cancers. Novel lncRNA biomarker in DLBCL needs to be investigated badly, as well as its function and molecular mechanism. To further explore, microarray analysis was performed to identify the differentially expressed lncRNAs in DLBCL tissues. To investigate the biological functions of SMAD5-AS1, we performed gain- and loss-of-function experiments in vitro and in vivo. Furthermore, bioinformatics analysis, dual-luciferase reporter assays, Argonaute 2-RNA immunoprecipitation (AGO2-RIP), RNA pull-down assay, quantitative PCR arrays, western blot assay, TOPFlash/FOPFlash reporter assay, and rescue experiments were conducted to explore the underlying mechanisms of competitive endogenous RNAs (ceRNAs). We found that SMAD5-AS1 was down-regulated in DLBCL tissues and cell lines. Functionally, SMAD5-AS1 downregulation promoted cell proliferation in vitro and in vivo, whereas SMAD5-AS1 overexpression could lead to the opposite effects in vitro and in vivo. Bioinformatics analysis and luciferase assays revealed that miR-135b-5p was a direct target of SMAD5-AS1, which was validated by dual-luciferase reporter assays, AGO2-RIP, RNA pull-down assay, and rescue experiments. Also, dual-luciferase reporter assays and rescue experiments demonstrated that miR-135b-5p targeted the adenomatous polyposis coli (APC) gene directly. SMAD5-AS1/miR-135b-5p inhibits the cell proliferation via inactivating the classic Wnt/β-catenin pathway in the form of APC dependency. Our results indicated that SMAD5-AS1 inhibits DLBCL proliferation by sponging miR-135b-5p to up-regulate APC expression and inactivate classic Wnt/β-catenin pathway, suggesting that SMAD5-AS1 may act as a potential biomarker and therapeutic target for DLBCL. |
format | Online Article Text |
id | pubmed-6420660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64206602019-03-18 Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC Zhao, Chen-Chen Jiao, Yang Zhang, Yi-Yin Ning, Jie Zhang, Yi-Ruo Xu, Jing Wei, Wei Kang-Sheng, Gu Cell Death Dis Article Diffuse large B cell lymphoma (DLBCL) is a common and fatal hematological malignancy. Long noncoding RNAs (lncRNAs) have emerged as crucial biomarkers and regulators in many cancers. Novel lncRNA biomarker in DLBCL needs to be investigated badly, as well as its function and molecular mechanism. To further explore, microarray analysis was performed to identify the differentially expressed lncRNAs in DLBCL tissues. To investigate the biological functions of SMAD5-AS1, we performed gain- and loss-of-function experiments in vitro and in vivo. Furthermore, bioinformatics analysis, dual-luciferase reporter assays, Argonaute 2-RNA immunoprecipitation (AGO2-RIP), RNA pull-down assay, quantitative PCR arrays, western blot assay, TOPFlash/FOPFlash reporter assay, and rescue experiments were conducted to explore the underlying mechanisms of competitive endogenous RNAs (ceRNAs). We found that SMAD5-AS1 was down-regulated in DLBCL tissues and cell lines. Functionally, SMAD5-AS1 downregulation promoted cell proliferation in vitro and in vivo, whereas SMAD5-AS1 overexpression could lead to the opposite effects in vitro and in vivo. Bioinformatics analysis and luciferase assays revealed that miR-135b-5p was a direct target of SMAD5-AS1, which was validated by dual-luciferase reporter assays, AGO2-RIP, RNA pull-down assay, and rescue experiments. Also, dual-luciferase reporter assays and rescue experiments demonstrated that miR-135b-5p targeted the adenomatous polyposis coli (APC) gene directly. SMAD5-AS1/miR-135b-5p inhibits the cell proliferation via inactivating the classic Wnt/β-catenin pathway in the form of APC dependency. Our results indicated that SMAD5-AS1 inhibits DLBCL proliferation by sponging miR-135b-5p to up-regulate APC expression and inactivate classic Wnt/β-catenin pathway, suggesting that SMAD5-AS1 may act as a potential biomarker and therapeutic target for DLBCL. Nature Publishing Group UK 2019-03-15 /pmc/articles/PMC6420660/ /pubmed/30874550 http://dx.doi.org/10.1038/s41419-019-1479-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zhao, Chen-Chen Jiao, Yang Zhang, Yi-Yin Ning, Jie Zhang, Yi-Ruo Xu, Jing Wei, Wei Kang-Sheng, Gu Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title | Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title_full | Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title_fullStr | Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title_full_unstemmed | Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title_short | Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC |
title_sort | lnc smad5-as1 as cerna inhibit proliferation of diffuse large b cell lymphoma via wnt/β-catenin pathway by sponging mir-135b-5p to elevate expression of apc |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420660/ https://www.ncbi.nlm.nih.gov/pubmed/30874550 http://dx.doi.org/10.1038/s41419-019-1479-3 |
work_keys_str_mv | AT zhaochenchen lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT jiaoyang lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT zhangyiyin lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT ningjie lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT zhangyiruo lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT xujing lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT weiwei lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc AT kangshenggu lncsmad5as1ascernainhibitproliferationofdiffuselargebcelllymphomaviawntbcateninpathwaybyspongingmir135b5ptoelevateexpressionofapc |